Metraipolis › archive › dc_7e1e45c72e85

Zinc Therapy in Mild Cognitive Impairment: Cognitive Stabilization in Pharmacodynamically Responsive Patients in the ZINCAiD Trial — Europe PMC PMID:41008575

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41008575
DOI
10.3390/biom15091268
License (as archived)
solo-consultazione
Archived
2026-11-10T05:36:58.543Z
SHA-256 of the archived text
477fa98bcc47900659f0ccc59d5d91cf6e230183715711f89d5fb4688abafdcd
Stable URL of this page
https://metraipolis.com/documento/dc_7e1e45c72e85

How to cite

Zinc Therapy in Mild Cognitive Impairment: Cognitive Stabilization in Pharmacodynamically Responsive Patients in the ZINCAiD Trial — Europe PMC PMID:41008575 — Europe PMC (en), https://europepmc.org/article/MED/41008575 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7e1e45c72e85 (Metraipolis archive dc_7e1e45c72e85, sha256 477fa98bcc47900659f0ccc59d5d91cf6e230183715711f89d5fb4688abafdcd)
BibTeX
@misc{dc7e1e45c72e85,
  title = {Zinc Therapy in Mild Cognitive Impairment: Cognitive Stabilization in Pharmacodynamically Responsive Patients in the ZINCAiD Trial — Europe PMC PMID:41008575},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41008575},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7e1e45c72e85; sha256 477fa98bcc47900659f0ccc59d5d91cf6e230183715711f89d5fb4688abafdcd},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41008575. Agents can read the archived copy with the MCP tool read_document.